Autotaxin in embryonic development

Moolenaar, Wouter H.; Houben, Anna J.S.; Lee, Shyh-Jye; Meeteren, Laurens A. van

doi:10.1016/j.bbalip.2012.09.013

Cited by 48 publications

(37 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ENPP2 Ϫ / Ϫ embryos have increased expression of vascular endothelial growth factor (VEGF) mRNA, consistent with hypoxic conditions as a consequence of the absence of a functional vascular system ( 46,47 ). The requirement of ATX in vascular development has also been established in zebrafi sh models ( 113,114 ), demonstrating that LPA or other products derived from ATX activity are required for embryonic blood vessel formation. S1P increases endothelial cell migration and angiogenesis ( 64,115 ).…”

Section: Nonredundant Functions Of the Lppsmentioning

confidence: 80%

Lipid phosphate phosphatases and their roles in mammalian physiology and pathology

Tang

Benesch

Brindley

2015

Journal of Lipid Research

119

130

View full text Add to dashboard Cite

Section: Nonredundant Functions Of the Lppsmentioning

confidence: 80%

Lipid phosphate phosphatases and their roles in mammalian physiology and pathology

Tang

Benesch

Brindley

2015

Journal of Lipid Research

119

130

View full text Add to dashboard Cite

“…Similarly to morphogens that modulate key aspects of both development and cancer progression as a consequence of spatiotemporal regulation ( 75 ), properly regulated expression and activity of ATX is crucial for embryogenesis ( 76 ). A number of studies have shown that ATX controls embryonic development by regulating vasculature maturation and angiogenesis.…”

Section: Role In Physiology and Cancer Pathophysiologymentioning

confidence: 99%

Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression

Federico

Jeong

Vellano

et al. 2016

Journal of Lipid Research

View full text Add to dashboard Cite

a 125 kDa glycoprotein composed of 915 amino acids ( 1 ). Because it promoted chemotaxis on melanoma cells in an autocrine fashion, the protein was aptly named auto-taxin. Four years after the discovery of the fi rst variant, now commonly referred to as ATX ␣ , or melanoma ATX, a second isoform was cloned by the same team from the teratocarcinoma cell line, Ntera2D1. This polypeptide shared 94% identity with the melanoma protein and was immediately recognized as the alternatively spliced product of the same gene ( 2 ).The initial characterization of the fi rst isoform revealed that ATX biological activity was sensitive to pertussis toxin treatment. Furthermore, not only did the polypeptide share close homology with the murine pyrophosphatase/ type I phosphodiesterase (PDE) PC-1, including a threonine residue crucial for PDE enzymatic activity, but it was also able to hydrolyze PDE substrates in vitro ( 3 ). The confi rmation that ATX was an enzyme came when a new PDE, the PDE1/nucleotide pyrophosphatase (PD-1 ␣ /PDNP 2), was cloned from a cDNA library of human retina and found to be identical to the sequence of melanoma ATX ␣ with the exception of a missing stretch of 52 amino acids encoded by exon 12 in the central region of the open reading frame. The transcript of this variant, now frequently referred to as ATX ␤ , or teratoma ATX, produced a 863 amino acid polypeptide chain with a mass of 99,034 Da ( 4 ), and was independently isolated a few years later in mouse tissues ( 5 ). The third ATX isoform was detected for the fi rst time in rat brain, but was originally designated as PD-I ␣ , a brain-specifi c PDE I/nucleotide pyrophosphatase ( 6 ). Further research showed that PD-I ␣ was identical to ATX ␤ teratoma protein, except for the presence of an additional stretch of 25 amino acids encoded by an alternatively Abstract The ectonucleotide pyrophosphatase/phosphodiesterase type 2, more commonly known as autotaxin (ATX), is an ecto-lysophospholipase D encoded by the human ENNP2 gene. ATX is expressed in multiple tissues and participates in numerous key physiologic and pathologic processes, including neural development, obesity, infl ammation, and oncogenesis, through the generation of the bioactive lipid, lysophosphatidic acid. Overwhelming evidence indicates that altered ATX activity leads to oncogenesis and cancer progression through the modulation of multiple hallmarks of cancer pathobiology. Here, we review the structural and catalytic characteristics of the ectoenzyme, how its expression and maturation processes are regulated, and how the systemic integration of its pleomorphic effects on cells and tissues may contribute to cancer initiation, progression, and therapy. Additionally, the up-to-date spectrum of the most frequent ATX genomic alterations from The Cancer Genome Atlas project is reported for a subset of cancers. ( Fig. 1 ). In 1992, the fi rst alternatively spliced isoform was cloned from the melanoma cell line, A2058, and characterized as STRUCTURE AND ENZYMATIC ACTIVITY ATX belongs to the nuc...

show abstract

“…48 ATX is a vital enzyme that is essential for early embryological development. 49 ATX homozygous knockout embryos die in utero on average at day 9.5 due to vascular and neural tube defects; ATX heterozygous knockout mice are viable, but they will develop pulmonary hypertension owing to hyper-response to hypoxia-induced vasoconstriction and remodeling. These illustrate the importance of the ATX-LPA axis in vascular and neural development.…”

Section: Atx/lpa Axismentioning

confidence: 99%

The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer

et al. 2017

View full text Add to dashboard Cite

Autotaxin, an ecto-lysophospholipase D encoded by the human ENNP2 gene, is expressed in multiple tissues, and participates in numerous critical physiologic and pathologic processes including inflammation, pain, obesity, embryo development, and cancer via the generation of the bioactive lipid lysophosphatidate. Overwhelming evidences indicate that the autotaxin/lysophosphatidate signaling axis serves key roles in the numerous processes central to tumorigenesis and progression, including proliferation, survival, migration, invasion, metastasis, cancer stem cell, tumor microenvironment, and treatment resistance by interacting with a series of at least six G-protein-coupled receptors (LPAR1-6). This review provides an overview of the autotaxin/lysophosphatidate axis and collates current knowledge regarding its specific role in pancreatic cancer. With a deeper understanding of the critical role of the autotaxin/lysophosphatidate axis in pancreatic cancer, targeting autotaxin or lysophosphatidate receptor may be a potential and promising strategy for cancer therapy.

show abstract

Autotaxin in embryonic development

Cited by 48 publications

References 58 publications

Lipid phosphate phosphatases and their roles in mammalian physiology and pathology

Lipid phosphate phosphatases and their roles in mammalian physiology and pathology

Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression

The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer

Contact Info

Product

Resources

About